STAT2h
New tests for Alzheimer’s and cancer get FDA’s ‘breakthrough’ status
PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...
Soleno Therapeutics announces FDA approval of VYKAT XR to treat hyperphagia
Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
US Senate confirms Trump's picks to lead FDA, NIH
The U.S. Senate on Tuesday confirmed President Donald Trump's nominees Martin Makary and Jay Bhattacharya as heads of the ...
8 AI Drug Discovery and Manufacturing Stocks to Buy
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
New Scientist16h
GLP-1 drugs are only the start – the powerful drugs to expect next
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...
Multiple Sclerosis News Today17h
FDA grants priority review to application for tolebrutinib for MS
A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...
SMA News Today18h
MDA 2025: Apitegromab could fill unmet SMA needs, executive says
In an interview, Scholar Rock's chief medical officer talks about benefits seen in clinical trials of its muscle-targeted SMA ...
Debate over the abortion pill mifepristone resurfaces after Makary is confirmed to head the FDA
President Donald Trump’s pick to lead the Food and Drug Administration, Dr. Marty Makary, was confirmed by the Senate late ...
Exelixis gets FDA label expansion for Cabometyx in neuroendocrine tumors
Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...